Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword
- PMID: 10529077
Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword
Similar articles
-
[Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].Ugeskr Laeger. 2005 Jan 10;167(2):153-5. Ugeskr Laeger. 2005. PMID: 15697124 Danish. No abstract available.
-
[Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].MMW Fortschr Med. 2001 Jun 21;143(25):58. MMW Fortschr Med. 2001. PMID: 11469003 German. No abstract available.
-
Calcium channel blocker.Clin Ther. 2010 Feb;32(2):396; author reply 397. doi: 10.1016/j.clinthera.2010.02.007. Clin Ther. 2010. PMID: 20206797 No abstract available.
-
Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.Drugs R D. 2002;3(5):324-30. doi: 10.2165/00126839-200203050-00006. Drugs R D. 2002. PMID: 12455153 Review. No abstract available.
-
Safety profile of lacidipine: a review of clinical data.J Cardiovasc Pharmacol. 1991;17 Suppl 4:S45-7. J Cardiovasc Pharmacol. 1991. PMID: 1726006 Review.
MeSH terms
Substances
LinkOut - more resources
Medical